Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
18.22
-0.36 (-1.94%)
Jul 30, 2026, 4:08 PM HKT

HKG:1877 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,9112,6152,5023,7885,9973,507
Short-Term Investments
----17.93-
Trading Asset Securities
650.44600.78430.51---
Cash & Short-Term Investments
4,5613,2162,9333,7886,0153,507
Cash Growth
50.91%9.65%-22.58%-37.02%71.53%3.59%
Accounts Receivable
459.67506.75509.82483.23232.731,301
Other Receivables
122.38-36.44374.0178.8128.05
Receivables
582.06506.75546.26857.23314.251,329
Inventory
562.43573.11584.47538.05599.02484.6
Prepaid Expenses
----239.82-
Other Current Assets
168.75162.01220.38387.5936.94524.79
Total Current Assets
5,8744,4584,2845,5717,2055,845
Property, Plant & Equipment
4,9514,8724,1953,8093,2782,801
Long-Term Investments
2,1351,9141,2261,1331,2921,485
Other Intangible Assets
550.69559.77521.41546.9698.91264.98
Long-Term Deferred Tax Assets
85.2588.3187.05103.4228.4388.55
Long-Term Deferred Charges
-9.766.1212.6-27.79
Other Long-Term Assets
555.42480.35461.94167.14473.39522.34
Total Assets
14,15212,38210,78211,34312,57611,035

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,00473.99115.9125.19370.2363.17
Accrued Expenses
268.72804.98901.441,046917.211,603
Short-Term Debt
729.11603.2678.11452.44391.75-
Current Portion of Long-Term Debt
618.82659.39216.586.96-10.6
Current Portion of Leases
-32.0130.2935.9343.6634.47
Current Income Taxes Payable
25.574.7612.4117.98-63.08
Current Unearned Revenue
67.922.188.17146.30.4445.8
Other Current Liabilities
31.67577.77531.11527.9250.96181.59
Total Current Liabilities
2,7462,7782,4942,4381,7742,001
Long-Term Debt
4,5752,7941,9801,196839.58490
Long-Term Leases
52.6256.6226.3117.4546.5993.13
Long-Term Unearned Revenue
159.89167.17181.91183.46121.62122.46
Other Long-Term Liabilities
528.24530.06168187.15-11.5
Total Liabilities
8,0626,3264,8504,0222,7822,719

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,0271,027985.69985.69982.87910.76
Additional Paid-In Capital
-16,41715,40715,395-11,423
Retained Earnings
-11,237-11,216-10,341-9,060--4,389
Treasury Stock
-30.89-30.89-30.89-26.89--
Comprehensive Income & Other
16,137-166.69-159.94-142.078,5190.21
Total Common Equity
5,8966,0305,8607,1519,5017,945
Minority Interest
194.0726.1671.71169.39292.83371.28
Shareholders' Equity
6,0906,0575,9327,3219,7948,316
Total Liabilities & Equity
14,15212,38210,78211,34312,57611,035

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
5,9754,1452,9311,7891,322628.19
Net Cash (Debt)
-1,414-928.981.822,0004,6932,878
Net Cash Growth
---99.91%-57.39%63.05%13.58%
Net Cash Per Share
-1.39-0.920.002.035.123.23
Filing Date Shares Outstanding
1,0261,026984.87985.01982.87910.76
Total Common Shares Outstanding
1,0261,026984.87985.01982.87910.76
Working Capital
3,1281,6791,7903,1335,4313,843
Book Value Per Share
5.755.885.957.269.678.72
Tangible Book Value
5,3455,4715,3396,6049,4037,680
Tangible Book Value Per Share
5.215.335.426.709.578.43
Buildings
-1,4251,3791,419-891.83
Machinery
-2,1612,0221,9211,5221,419
Construction In Progress
-2,5721,8591,3251,048801.93
Leasehold Improvements
----65.57-